BMIPP Compared with Thallium Redistribution

Overview

Journal Int J Card Imaging

Specialties Cardiology & Vascular Diseases
Radiology

Date 1999 Aug 24

PMID 10453403

Citations 1

Authors

J Taki

I Matsunari

K Nakajima

N Tonami

Affiliations

Soon will be listed here.

Abstract

I-123 labeled methyl-branched fatty acid, BMIPP, has been used mainly in Europe and Japan for the evaluation of various cardiac diseases. BMIPP uptake abnormality is usually more prominent tan perfusion, representing discordant BMIPP uptake less than thallium. This finding is observed in various cardiac disease conditions such as acute myocardial infarction, stable and unstable angina, hypertrophic and dilated cardiomyopathies. Many BMIPP studies combined stress thallium imaging in patients with coronary artery disease and hypertrophic cardiomyopathy demonstrated that such discordant BMIPP uptake less than thallium is related to stress-induced ischemia as evidenced by reversible thallium defect after exercise. BMIPP imaging is able to detect metabolic alteration in the heart which is not available by perfusion imaging alone.

Citing Articles

Serial evaluation of fatty acid metabolism in rats with myocardial infarction by pinhole SPECT.

Hirai T, Nohara R, Ogoh S, Chen L, Kataoka K, Li X J Nucl Cardiol. 2001; 8(4):472-81.

PMID: 11481570 DOI: 10.1067/mnc.2001.114519.

References

Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T . Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection. Am Heart J. 1996; 131(3):458-65. DOI: 10.1016/s0002-8703(96)90523-2. View

Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H . Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med. 1992; 19(9):775-82. DOI: 10.1007/BF00182819. View

Taki J, Nakajima K, Matsunari I, Bunko H, Takata S, Kawasuji M . Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med. 1997; 38(10):1503-10. View

Hwang E, Taki J, Yasue S, Fujimoto M, Taniguchi M, Matsunari I . Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency. J Nucl Med. 1998; 39(10):1681-4. View

Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N . Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med. 1990; 31(11):1818-22. View

Camici P, Ferrannini E, Opie L . Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 1989; 32(3):217-38. DOI: 10.1016/0033-0620(89)90027-3. View

Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N . Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med. 1992; 33(1):6-13. View

Van Nieuwenhoven F, Verstijnen C, Abumrad N, Willemsen P, Van Eys G, Van der Vusse G . Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem Biophys Res Commun. 1995; 207(2):747-52. DOI: 10.1006/bbrc.1995.1250. View

Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J . Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med. 1992; 33(5):659-67. View

10.

Suzuki A, Takada Y, Nagasaka M, Kato R, Watanabe T, Shimokata K . Comparison of resting beta-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina. Jpn Circ J. 1997; 61(2):133-8. DOI: 10.1253/jcj.61.133. View

11.

Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y . Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med. 1994; 8(1):47-54. DOI: 10.1007/BF03164986. View

12.

Tamaki N, Tadamura E, Kudoh T, Hattori N, Yonekura Y, Nohara R . Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med. 1996; 23(3):272-9. DOI: 10.1007/BF00837625. View

13.

Matsuo S, Nakamura Y, Takahashi M, Mitsunami K, Kinoshita M . Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J. 1998; 62(3):167-72. DOI: 10.1253/jcj.62.167. View

14.

Cannon 3rd R, Dilsizian V, OGara P, Udelson J, Schenke W, Quyyumi A . Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation. 1991; 83(5):1660-7. DOI: 10.1161/01.cir.83.5.1660. View

15.

Hwang E, Yamashita A, Takemori H, Taki J, Nakajima K, Bunko H . Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med. 1996; 10(4):445-8. DOI: 10.1007/BF03164809. View

16.

Kubota K, Som P, OSTER Z, Brill A, Goodman M, Knapp Jr F . Detection of cardiomyopathy in an animal model using quantitative autoradiography. J Nucl Med. 1988; 29(10):1697-703. View

17.

Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, SUKEKAWA H, Tomoike H . Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy. J Nucl Med. 1997; 38(9):1407-11. View

18.

Nishimura T, Uehara T, Shimonagata T, Nagata S, Haze K . Clinical results with beta-methyl-p-(123I)iodophenylpentadecanoic acid, single-photon emission computed tomography in cardiac disease. J Nucl Cardiol. 1994; 1(2 Pt 2):S65-71. DOI: 10.1007/BF02940071. View

19.

Ito T, Tanouchi J, Kato J, Morioka T, Nishino M, Iwai K . Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123I-BMIPP and 201Tl SPET images. Eur J Nucl Med. 1996; 23(8):917-23. DOI: 10.1007/BF01084365. View

20.

Dudczak R, Schmoliner R, Angelberger P, Knapp F, Goodman M . Structurally modified fatty acids: clinical potential as tracers of metabolism. Eur J Nucl Med. 1986; 12 Suppl:S45-8. DOI: 10.1007/BF00258104. View